Newsfeeds Archive - Page 375 of 19074

1 minute read

BridgeBio Pharma Shares One Year Data From Dwarfism Candidate

June 4, 3:29 PM

BridgeBio Pharma revealed results from the PROPEL 2 Phase 2 trial of infigratinib in children with achondroplasia. Key data shows sustained increases in height velocity and improved body proportionality with a good safety profile.

BBIO

2 minute read

Doom And Gloom In Office Space Real Estate? Delinquency Data Tells Another Story

By Hayden Buckfire

June 4, 3:24 PM

Delinquency data suggests office real estate may not be as doomed as Wall Street predicts. Current rates are low compared to historic peaks.

XLRE

2 minute read

Uncategorized

Nvidia’s Future Unveiled By CEO Jensen Huang Followed By A 5% Stock Surge Amid Anticipated 10-For-1 Stock Split

By Zaheer Anwari

June 4, 3:21 PM

Nvidia's announcement of a 10-for-1 stock split, scheduled for June 10, could attract a larger pool of investors. The stock surged nearly 5% by the close of trading on Monday.

NVDA

2 minute read

This Wallet Spent $2M On ‘Crazy Buy’ Of 135M GME Meme Coins

By Khyathi Dalal

June 4, 3:19 PM

Lookonchain data highlighted a new wallet trading the GameStop (CRYPTO: GME) meme coin, instantly making it one of the largest holders.

SOL

2 minute read

Sanofi Highlights Data From Blood Cancer Drug Sarclisa In New Diagnosed Multiple Myeloma Patients

By Vandana Singh

June 4, 3:18 PM

Sanofi's phase 3 IMROZ study shows Sarclisa with VRd significantly improves progression-free survival in newly diagnosed, transplant-ineligible multiple myeloma patients.

SNY

3 minute read

A Closer Look at Celsius Holdings’s Options Market Dynamics

By Benzinga Insights

June 4, 3:15 PM

Deep-pocketed investors have adopted a bearish approach towards Celsius Holdings (NASDAQ:CELH), and it’s something market players shouldn’t ignore.…

CELH

2 minute read

UiPath Options Trading: A Deep Dive into Market Sentiment

By Benzinga Insights

June 4, 3:15 PM

Deep-pocketed investors have adopted a bullish approach towards UiPath (NYSE:PATH), and it’s something market players shouldn’t ignore. Our…

PATH

2 minute read

Lululemon Athletica Recovering From Merchandising Missteps, Says Analyst

By Shivani Kumaresan

June 4, 3:10 PM

Oppenheimer analyst Brian Nagel reiterated an Outperform rating for Lululemon Athletica with a $445 price target. Despite a 35% drop in shares post-Q4 results, Nagel remains optimistic, noting a stable EPS forecast and potential recovery from merchandising missteps.

LULU

2 minute read

Mike Novogratz Predicts Bitcoin To $100K By The End Of 2024

By Murtuza Merchant

June 4, 3:10 PM

Galaxy Digital CEO Michael Novogratz has reiterated his bullish stance on Bitcoin, predicting a price of $100,000 by the end of 2024.

BTC

1 minute read

Cryptocurrency Arweave Rises More Than 5% In 24 hours

By Benzinga Insights

June 4, 3:03 PM

Over the past 24 hours, Arweave's (CRYPTO: AR) price has risen 5.68% to $45.66. This continues its positive trend over the past week where it has experienced a 21.0% gain, moving from $37.87 to its current price. As it stands right now, the coin's all-time high is $89.24.